Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri.
J Surg Oncol. 2014 Oct;110(5):629-35. doi: 10.1002/jso.23723. Epub 2014 Aug 6.
The impact of comorbidities on treatment, postoperative complications, survival, prognosis, and quality of life, makes comorbidities' assessment essential in surgically managed cancer patients. Multiple indices exist to measure the presence and severity of comorbidities, of which the Charlson Comorbidity Index and the Adult Comorbidity Evaluation-27 are the most widely employed. Incorporation of comorbidity data in cancer registries facilitates surgical oncology research conduct with an objective to improve cancer care through better-informed patient counseling and treatment planning.
合并症对治疗、术后并发症、生存、预后和生活质量的影响，使得合并症评估在接受手术治疗的癌症患者中至关重要。有多种指标用于衡量合并症的存在和严重程度，其中 Charlson 合并症指数和成人合并症评估-27 应用最广泛。在癌症登记处中纳入合并症数据有助于进行肿瘤外科研究，目的是通过更有针对性的患者咨询和治疗计划来改善癌症护理。
